[1]
Bruggmann, P., Senn, O., Frei, A., Puhan, M.A., Fehr, J. and Falcato, L. 2022. High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study. Swiss Medical Weekly. 152, 0102 (Jan. 2022), w30122. DOI:https://doi.org/10.4414/SMW.2022.w30122.